Contents
show
A Quick Look at Tirzepatide
Tirzepatide is an injected medication that was first used primarily to treat type 2 diabetes. It’s a combination medication with a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Although tirzepatide was initially approved by the FDA to improve blood sugar control in patients with diabetes, it was later FDA-approved for chronic weight management in patients with or without diabetes. It works by lowering blood glucose, reducing hunger signals, and helping you feel more full for a longer time. Could it be right for you?The Eligibility Criteria for Tirzepatide
Tirzepatide is generally prescribed for chronic weight management in people who have a body mass index (BMI) of 30 or higher. However, even if your BMI is lower than 30, you might still be eligible. It can also be prescribed to people with a BMI of at least 27 who also have at least one weight-related health condition. A weight-related health condition is a health problem that can be better managed by losing weight. These include:- Diabetes
- High cholesterol
- Sleep apnea
- High blood pressure
Contraindications of Tirzepatide
A contraindication is a factor that may disqualify a patient from being eligible from using the medication, even if they otherwise meet the eligibility criteria. To safeguard your wellness, it’s important to fully disclose your health history (including your family medical history) to your medical weight loss provider. Some possible contraindications of tirzepatide can include:- Current, planned, or possible pregnancy
- Breastfeeding
- Pancreatitis
- Kidney disease
- History of severe depression with suicidal thoughts
- Gastroparesis
- Thyroid cancer
- Multiple endocrine neoplasia syndrome type 2
- Type 1 diabetes
- Diabetic retinopathy